Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Review
DOI: 10.1055/s-0038-1669391
Submitted: 03-06-2022
Published: 03-06-2022

Transplante de microbiota fecal no tratamento da infecção por Clostridium difficile recorrente—uma revisão

Clínica Médica, Hospital Geral Ernesto Simões Filho, Salvador, BA, Brasil
Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brasil
Clínica Médica, Hospital Português da Bahia, Salvador, BA, Brasil
Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brasil
Internal Medicine Department, Hospital Meridional, Cariacica, ES, Brasil
clostridium difficile recurrent diarrhea fecal microbiota transplantation

Abstract

Clostridium difficile infection (CDI) has become one of the major complications associated with the use of systemic antibiotics. Antimicrobials disrupt the balance of the colonic intestinal flora, predisposing the individual to infections by opportunistic strains, such as an CDI, that can characteristically cause a course of diarrhea and colitis. The standard treatment for these cases is the use of metronidazole or vancomycin for a period of 10 to 14 days. However, it is estimated that this therapy will fail in ∼ 5 to 35% of the patients, who will present a recurrence of CDI. The treatment options for recurrent CDI remain limited, but with promising therapies being constantly researched. The use of stools obtained from a donor to perform fecal microbiota transplantation (FMT) has been gaining space in several health centers, with reported success rates of 80 to 100%. However, there still is a limited experience in this subject, with the need for studies that allow the creation of a specific protocol for FMT.

Metrics

Metrics Loading ...

References

  1. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with humanmotions. J Clin Gastroenterol 2004;38(06):475–483http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200407000-00003[Internet]
  2. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011;9(01):27–38http://www.nature.com/doifinder/10.1038/nrmicro2473[Internet]
  3. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011;32(04):387–390
  4. Depestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract 2013;26(05):464–475
  5. Wilcox MH. Treatment of Clostridium difficile infection. J Antimicrob Chemother 1998;41(Suppl C):41–46http://www.ncbi.nlm.nih.gov/pubmed/9630373[Internet]
  6. Huebner ES, Surawicz CM. Treatment of Recurrent Clostridium difficile Diarrhea. Gastroenterol Hepatol (N Y) 2006;2(03):203–208
  7. Xu S, Huang H, Li G. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of america (SHEA) and the infectious diseases society of America (IDSA). Chinese J Infect Chemother. 2011;11(06):426–427
  8. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009;15(06):285–289. Doi: 10.1016/j.anaerobe.2009.09.007 [Internet]
  9. Bakken JS, Borody T, Brandt LJ, et al; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011;9(12):1044–1049. Doi: 10.1016/j.cgh.2011.08.014 [Internet]
  10. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368(05):407–415http://www.nejm.org/doi/10.1056/NEJMoa12050 37[Internet]
  11. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53(10):994–1002
  12. Cresci GA, Bawden E. Gut Microbiome: What We Do and Don’t Know. Nutr Clin Pract 2015;30(06):734–746http://www.ncbi.nlm.nih.gov/pubmed/26449893%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4838018 [Internet]
  13. Del Fiol FdeS, Lopes LC, Toledo MI, Barberato-Filho S. Prescription patterns and antibiotic use in community-based infections. Rev Soc Bras Med Trop 2010;43(01):68–72
  14. Sancho-Puchades M, Herráez-Vilas JM, Valmaseda-Castellón E, Berini-Aytés L, Gay-Escoda C. Analysis of the antibiotic prophylaxis prescribed by Spanish Oral Surgeons. Med Oral Patol Oral Cir Bucal 2009;14(10):e533–e537
  15. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008;197(03):435–438https://academic.oup.com/jid/article-lookup/doi/10.1086/525047[Internet]
  16. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700 year-old fecal microbiota transplantation? Am J Gastroenterol 2012;107(11):1755–1755, author reply 1755–1756
  17. Merde LA. Excursions in Scientific, Cultural, and Socio-Historical Coprology. 1815;119(4):1174–1175
  18. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44(05):854–859
  19. McCune VL, Struthers JK, Hawkey PM. Faecal transplantation for the treatment of Clostridium difficile infection: a review. Int J Antimicrob Agents 2014;43(03):201–206
  20. Bowden TA Jr, Mansberger AR Jr, Lykins LE. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 1981;47(04):178–183
  21. Varier RU, Biltaji E, Smith KJ, et al. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 2015;36(04):438–444 https://www.cambridge.org/core/product/identifier/S0899823X14000804/type/journal_article[Internet]
  22. Paramsothy S, Borody TJ, Lin E, et al. Donor Recruitment for Fecal Microbiota Transplantation. Inflamm Bowel Dis 2015;21 (07):1600–1606http://content.wkhealth.com/linkback/openurl?sid=WKP TLP:landingpage&an=00054725-201507000-00014 [Internet]
  23. Weingarden A, González A, Vázquez-Baeza Y, et al. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome 2015;3(01):10 http://www.microbiomejournal.com/content/3/1/10 [Internet]
  24. Daloiso V, Minacori R, Refolo P, et al. Ethical aspects of Fecal Microbiota Transplantation (FMT). Eur Rev Med Pharmacol Sci 2015;19(17):3173–3180

How to Cite

Meneses, R. B., Filardi, K. F. X. C., Bagano, P. F. da C., Machado, R. G., & Fernandes, S. L. (2022). Transplante de microbiota fecal no tratamento da infecção por Clostridium difficile recorrente—uma revisão. International Journal of Nutrology, 11(2), 51–55. https://doi.org/10.1055/s-0038-1669391